Recent advances and current state of immunotherapy in systemic lupus erythematosus.

about

Metabolic Factors that Contribute to Lupus Pathogenesis Catalytic antibodies in patients with systemic lupus erythematosus

P2860

Q37612885-33FE29C4-0308-42B0-93B5-00BC4FEE4B99 Q58796857-47CB2C9E-C46B-4880-A1CD-CC258CFD733B

P2860

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q38794663

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

@en

type

Item

label

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

@en

prefLabel

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

@en

P1476

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

@en

P2093

Mo Yin Mok

http://www.w3.org/2001/XMLSchema#string

P2860

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research

The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus

Innate immune recognition

Multilineage potential of adult human mesenchymal stem cells

Dendritic cells and the control of immunity

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

BAFF, APRIL and their receptors: structure, function and signaling

P304

927-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2016.1171840

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

P577

2016-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27032059

http://www.w3.org/2001/XMLSchema#string

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

about

P2860

P2860

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698